Background: The use of antiplatelet therapy in combination with oral ... combination-therapy cohort were more likely to have had anticoagulation-related hemorrhages (4.2% vs 2.0%, respectively ...

Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort study found. In Ontario, people with atrial fibrillation (Afib) on OAC ...

Triple therapy of oral anticoagulation plus aspirin and clopidogrel or dual antiplatelet therapy is recommended for the initial prevention of thrombotic complications, but its duration should be ...

The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

She agrees that anticoagulation is not required in ... Bleeding risks with non-vitamin K oral anticoagulants versus single antiplatelet therapy: A systematic review and meta-analysis of randomized ...

Objectives The aim of the present study was to investigate the association of high-sensitivity C-reactive protein (hs-CRP) with bleeding events among patients with acute coronary syndrome (ACS) ...

Nearly 1 in 6 patients hospitalized for SARS‐CoV‐2 infection in the American Heart Association's COVID‐19 Cardiovascular Disease Registry did not receive prophylactic anticoagulation between May 2020 ...

All of the studies used aspirin as the antiplatelet therapy. The researchers found ... NOACs compared with aspirin when used for extended anticoagulation in this population," the authors write.